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Appendix Figure S1 . Release of gal-encapsulated fluorophores in xenografts A, Schematic representation of the synthesis of the GalNP beads. First, a super-micellartemplate is formed in basic water solution. Next, the inorganic siliceous precursor tetraethylortosilicate hydrolyses and condensates of around the template. The final mesoporous inorganic MCM-41 scaffold, which presents cylindrical unidirectional empty channels arranged in a hexagonal distribution, is obtained by the removal of the surfactant template by calcination. Next, the cargo is loaded in the mesopores and, finally, the beads are encapsulated with 6-mer galacto-oligosaccharides that will act as molecular gate to obtain the final GalNP system. Scale bar: 50 nm B, Powder X-ray patterns of solids MSNs as-synthesized, NPs calcined, GosNP(rho) and GalNP(rho). The XRD of NPs as-synthesized (curve a) shows the typical four low-angle reflections of a hexagonal ordered array indexed as (100), (110), (200), and (210) Bragg peaks. In curve b, corresponding to the NPs calcined sample, a significant shift of the (100) reflection in the XRD is clearly observed. This displacement, together with the broadening of the (110) and (200) reflections, is consistent with an approximate cell contraction of ca. 6-8 Å and attributed to the condensation of silanols during the calcination step. XRD patterns for solids GosNP(rho) and GalNP(rho) (curves c and d, respectively). For these materials, the reflections (110) and (200) are lost, most likely due to a reduction of contrast. Nevertheless, the presence of the d 100 peak in the XRD patterns in all cases indicated that the process of pore loading and the additional functionalization with the corresponding saccharides, did not to a large extent modify the mesoporous scaffolding. GosNP(icg), GalNP(dox) and GalNP(nav) show XRD profiles similar to those from GosNP(rho) and GalNP(rho). C, TEM analysis showing the presence of the mesoporous structure in the final functionalized solids. The typical channels of the MSNs matrix are visualized as alternate black and white stripes (NPs calcined (a) and GalNP(rho) (b)). The figure also shows that the prepared NPs-based materials are obtained as spherical particles with diameter ca. 100 nm. GosNP(rho), GosNP(icg), GalNP(dox) and GalNP(nav) show TEM images similar to this for GalNP(rho). Scale bars: 50 nm. D, Panel a, N 2 adsorption-desorption isotherms of the calcined NPs. A typical curve for these mesoporous solids consisting of an adsorption step at intermediate P/P 0 value (0.1-0.3) can be observed. This curve corresponds to a type IV isotherm, in which the observed step deals with nitrogen condensation inside the mesopores. The absence of a hysteresis loop in this interval and the narrow BJH pore distribution suggest the existence of uniform cylindrical mesopores (pore diameter of 2.51 nm and pore volume of 0.72 cm 3 g -1 calculated by using the BJH model on the adsorption branch of the isotherm). The application of the BET model resulted in a value of 996 m 2 /g for the total specific surface. Panels b and c, N 2 adsorption-desorption isotherm of GosNP(rho) and GalNP(rho), respectively. The isotherms are typical of mesoporous systems with practically filled mesopores. Consequently, relatively low N 2 adsorbed volume (BJH mesopore volume = 0.436 cm 3 g -1 and 0.418 cm 3 g -1 respectively) and surface area (197 m 2 /g and 373 m 2 /g) values were calculated. These solids show flat curves when compared (at the same scale) to those of the NPs parent material, which indicates significant pore blocking and the subsequent absence of significant mesoporosity. GosNP(icg), GalNP(dox) and GalNP(nav) show similar N 2 adsorption-desorption isotherms to that shown by GosNP(rho) and GalNP(rho). E, Cargo release studies of the GosNP(rho), GosNP(icg), GalNP(rho), GalNP(dox) and GalNP(nav) beads by spectrofluorometry. The graphs represent the release profiles of the cargoes in the absence (a) or the presence (b) of b-galactosidase from Aspergillus oryzae in water at pH 4.5 at room temperature at the indicated time points. F, NCI-H226 lung squamous carcinoma cells were treated with palbociclib (1 µM) for 1 week, and senescence induction was assessed by SAbGal staining. Next, cultures were exposed to GalNP(rho) (50 µg/ml, for 16 h). Pictures show representative images illustrating rhodamine release by confocal microscopy. Cells were co-stained with Calcein and nuclei were stained with Hoechst. Rhodamine intensity relative to cell surface was quantified using Definiens software. Graphs to the left right show the percentage of senescent cells with rhodamine intensity > 95% of the non-senescent cells (control) cells. Each assay was repeated at least three times with similar results. Scale bar: 50 µm. G, UT-SCC-42B head and neck squamous carcinoma cells were treated with palbociclib and GalNP(rho) as in F. The graph shows the percentage of senescent cells with rhodamine intensity > 95% of the non-senescent cells (control) cells. Each assay was repeated at least three times with similar results. H, SK-MEL-103 cells were treated with palbociclib (5 µM) for 2 weeks and exposed to GalNP(rho) (1 mg/ml filtered, for 16 h). Lysosomes were stained with lysotracker green for colocalization studies. Scale bar: 50 µm I, Subcutaneous SK-MEL-103 tumor xenograft, liver and spleen of athymic nude mice treated with palbociclib and GalNP(rho) as in Figure 1D . At 6 h post-injection, mice were sacrificed, tumors and organs were collected, and rhodamine fluorescence was analyzed by an IVIS spectrum imaging system. J, Subcutaneous tumor xenografts of SK-MEL-103 melanoma cells in athymic nude mice. Upon tumor formation (average volume 200 mm 3 ), mice were treated daily with palbociclib (oral gavage, 80 mg/kg) during 7 days. Mice were tail vein injected with 150 µl of a solution containing GalNP(icg) (10 mg/ml). At 16 h post-injection, mice were sacrificed, tumors were collected, and fluorescence was analyzed by an IVIS spectrum imaging system. K, Subcutaneous tumor xenografts of NCI-H226 lung squamous carcinoma cells in athymic nude mice. Upon tumor formation (average volume 200 mm 3 ), mice were treated daily with palbociclib (oral gavage, 100 mg/kg) during 15 days (weekdays). Mice were tail vein injected with 200 µl of a solution containing GalNP(icg) (10 mg/ml). At 16 h post-injection, mice were sacrificed, tumors were collected, and fluorescence was analyzed by an IVIS spectrum imaging system. Appendix Figure S2 (page 2 out of 2)
Appendix Figure S2. Release of gal-encapsulated fluorophores in fibrotic lungs
A, C57BL/6 mice were subjected to a single intratracheal administration of bleomycin (1.5 U/kg). 2 weeks later, mice were intratracheally injected with 30 µl of a solution containing GalNP(rho) (4 mg/ml). At 6 h post-inoculation, mice were sacrificed and the lungs were analyzed by an IVIS spectrum imaging system. B, Biodistribution studies of the GalNP silica scaffold in lung, liver, spleen, bladder, kidney, heart, gut and tail. Control and bleomycin-treated C57BL/6 mice were tail vein injected with 200 µl of a solution containing GalNP(rho) (4 mg/ml). At 6 h postGalNP(rho) injection the indicated organs were extracted for Si detection. The graph shows the µg Si per g of sample detected by Inductively Coupled Plasma Mass Spectroscopy (ICP-MS) in the indicated organs. C, Gating strategy used to exclude endothelial and haematopoietic cells. The example is illustrated with the same bleomycin-treated lung shown in Fig. 2D . Cells were sorted using pulse processing to exclude cell aggregates; DAPI was used as dead discriminator; and CD45 and CD31 were used to exclude endothelial (CD31+) 
